John Kerr posted in corn • enzyme deficiency • GM • GMO • lysomal storage • maize • rare disease on September 19th, 2012.
A treatment for a rare disease, which could previously only be manufactured by expensive cell culture techniques, may now be produced by greenhouse-grown maize. The findings, published today in Nature Communications, could dramatically decrease the cost of treating patients with a rare, but life-threatening inherited disease. Researchers created transgenic maize seeds which can synthesize alpha-L-iduronidase, […]
Continue reading “Drugs “on-the-cob” could provide cheaper therapies”